Abstract
Genetic Engineering & Biotechnology NewsVol. 42, No. 12 OMICSAutomating DNA Synthesis Boosts Drug DiscoveryTelesis Bio says that when synthetic biology is on the benchtop, it is in a position to help pharma and biotech firms expand their pipelinesJyotsna Venugopal, PhDJyotsna Venugopal, PhDJyotsna Venugopal, PhD, is director of product marketing at Telesis Bio. Website: telesisbio.com.Search for more papers by this authorPublished Online:9 Dec 2022https://doi.org/10.1089/gen.42.12.09AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 42Issue 12Dec 2022 Information© 2022 by GEN PublishingTo cite this article:Jyotsna Venugopal, PhD.Automating DNA Synthesis Boosts Drug Discovery.Genetic Engineering & Biotechnology News.Dec 2022.24-26.http://doi.org/10.1089/gen.42.12.09Published in Volume: 42 Issue 12: December 9, 2022PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
